Arrowhead Pharmaceuticals (STU:HDP1) Price-to-Operating-Cash-Flow : (As of May. 26, 2024)

View and export this data going back to 1997. Start your Free Trial

What is Arrowhead Pharmaceuticals Price-to-Operating-Cash-Flow?

As of today (2024-05-26), Arrowhead Pharmaceuticals's share price is €22.88. Arrowhead Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-2.10. Hence, Arrowhead Pharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Arrowhead Pharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, Arrowhead Pharmaceuticals's highest Price-to-Operating-Cash-Flow Ratio was 52.42. The lowest was 9.54. And the median was 31.82.

STU:HDP1's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.275
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Arrowhead Pharmaceuticals's Cash Flow from Operations per share for the three months ended in Mar. 2024 was €-0.69. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-2.10.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -14.90% per year.

During the past 13 years, Arrowhead Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 66.70% per year. The lowest was -122.20% per year. And the median was 9.90% per year.

Arrowhead Pharmaceuticals Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Arrowhead Pharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arrowhead Pharmaceuticals Price-to-Operating-Cash-Flow Chart

Arrowhead Pharmaceuticals Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

16.06

37.81

Arrowhead Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Arrowhead Pharmaceuticals's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Arrowhead Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arrowhead Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arrowhead Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Arrowhead Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Arrowhead Pharmaceuticals Price-to-Operating-Cash-Flow Calculation

Arrowhead Pharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	22.88	/	-2.101
	=

Arrowhead Pharmaceuticals's Share Price of today is €22.88.
Arrowhead Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.10.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Arrowhead Pharmaceuticals Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Arrowhead Pharmaceuticals's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Arrowhead Pharmaceuticals (STU:HDP1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arrowhead Pharmaceuticals Inc (STU:HDP1) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

ARWR:USA

Address

177 E. Colorado Boulevard, Suite 700, Pasadena, CA, USA, 91105

Website

https://www.arrowheadpharma.com

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Arrowhead Pharmaceuticals (STU:HDP1) Headlines

No Headlines